Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Expression profiling based on graph-clustering approach to determine colon cancer pathway.

Zhu XQ, Hu ML, Zhang F, Tao Y, Wu CM, Lin SZ, He FL.

J Cancer Res Ther. 2013 Jul-Sep;9(3):467-70. doi: 10.4103/0973-1482.119351.

2.

Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.

Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ.

BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16.

3.

Mining patterns in disease classification forests.

Hu H.

J Biomed Inform. 2010 Oct;43(5):820-7. doi: 10.1016/j.jbi.2010.06.004. Epub 2010 Jun 23.

4.

Bioinformatic analyses revealed underlying biological functions correlated with oxaliplatin responsiveness.

Klahan S, Huang CC, Chien SC, Wu MS, Wong HS, Huang CY, Chang WC, Wei PL.

Tumour Biol. 2016 Jan;37(1):583-90. doi: 10.1007/s13277-015-3807-2. Epub 2015 Aug 2.

PMID:
26232912
5.

Incremental fuzzy mining of gene expression data for gene function prediction.

Ma PC, Chan KC.

IEEE Trans Biomed Eng. 2011 May;58(5):1246-52. doi: 10.1109/TBME.2010.2047724. Epub 2010 Apr 15.

PMID:
20403777
6.

Gene Co-expression analysis predicts genetic aberration loci associated with colon cancer metastasis.

Zhang J, Ni S, Xiang Y, Parvin JD, Yang Y, Zhou Y, Huang K.

Int J Comput Biol Drug Des. 2013;6(1-2):60-71. doi: 10.1504/IJCBDD.2013.052202. Epub 2013 Feb 21.

PMID:
23428474
7.

Dynamic biclustering of microarray data by multi-objective immune optimization.

Liu J, Li Z, Hu X, Chen Y, Park EK.

BMC Genomics. 2011;12 Suppl 2:S11. doi: 10.1186/1471-2164-12-S2-S11. Epub 2011 Jul 27.

8.

Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer.

Li JN, Zhao L, Wu J, Wu B, Yang H, Zhang HH, Qian JM.

J Dig Dis. 2012 Jan;13(1):24-32. doi: 10.1111/j.1751-2980.2011.00551.x.

PMID:
22188913
9.

Expression profiling based on graph-clustering approach to determine osteoarthritis related pathway.

Zhang B, Xie QG, Quan Y, Pan XM.

Eur Rev Med Pharmacol Sci. 2013;17(15):2097-102.

10.

FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS.

Durmaz A, Henderson TAD, Brubaker D, Bebek G.

Pac Symp Biocomput. 2017;22:402-413. doi: 10.1142/9789813207813_0038.

11.

Multistage gene expression profiling in a differentially susceptible mouse colon cancer model.

Guda K, Cui H, Garg S, Dong M, Nambiar PR, Achenie LE, Rosenberg DW.

Cancer Lett. 2003 Feb 28;191(1):17-25.

PMID:
12609705
12.

Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles.

Türeci O, Ding J, Hilton H, Bian H, Ohkawa H, Braxenthaler M, Seitz G, Raddrizzani L, Friess H, Buchler M, Sahin U, Hammer J.

FASEB J. 2003 Mar;17(3):376-85.

PMID:
12631577
13.

Gene regulatory network from microarray data of colon cancer patients using TSK-type recurrent neural fuzzy network.

Vineetha S, Chandra Shekara Bhat C, Idicula SM.

Gene. 2012 Sep 15;506(2):408-16. doi: 10.1016/j.gene.2012.06.042. Epub 2012 Jul 1.

PMID:
22759510
14.

Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon.

Zou TT, Selaru FM, Xu Y, Shustova V, Yin J, Mori Y, Shibata D, Sato F, Wang S, Olaru A, Deacu E, Liu TC, Abraham JM, Meltzer SJ.

Oncogene. 2002 Jul 18;21(31):4855-62.

15.

The correlation of gene expression and co-regulated gene patterns in characteristic KEGG pathways.

Hua L, Li DG, Lin H, Li L, Li X, Liu ZC.

J Theor Biol. 2010 Sep 21;266(2):242-9. doi: 10.1016/j.jtbi.2010.06.029. Epub 2010 Jun 25.

PMID:
20599549
16.

Molecular signature of cancer at gene level or pathway level? Case studies of colorectal cancer and prostate cancer microarray data.

Chen J, Wang Y, Shen B, Zhang D.

Comput Math Methods Med. 2013;2013:909525. doi: 10.1155/2013/909525. Epub 2013 Jan 16.

17.

Cancer DNA microarray analysis considering multi-subclass with graph-based clustering method.

Kawamura T, Mutoh H, Tomita Y, Kato R, Honda H.

J Biosci Bioeng. 2008 Nov;106(5):442-8. doi: 10.1263/jbb.106.442.

PMID:
19111639
18.

Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients.

Leclerc D, Lévesque N, Cao Y, Deng L, Wu Q, Powell J, Sapienza C, Rozen R.

Cancer Prev Res (Phila). 2013 Nov;6(11):1171-81. doi: 10.1158/1940-6207.CAPR-13-0198. Epub 2013 Oct 29.

19.

Multi-class clustering of cancer subtypes through SVM based ensemble of pareto-optimal solutions for gene marker identification.

Mukhopadhyay A, Bandyopadhyay S, Maulik U.

PLoS One. 2010 Nov 12;5(11):e13803. doi: 10.1371/journal.pone.0013803.

20.

Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon.

Maglietta R, Liuzzi VC, Cattaneo E, Laczko E, Piepoli A, Panza A, Carella M, Palumbo O, Staiano T, Buffoli F, Andriulli A, Marra G, Ancona N.

BMC Cancer. 2012 Dec 19;12:608. doi: 10.1186/1471-2407-12-608.

Supplemental Content

Support Center